Auranofin

An oral chrysotherapeutic agent for the treatment of rheumatoid arthritis. Its exact mechanism of action is unknown, but it is believed to act via immunological mechanisms and alteration of lysosomal enzyme activity. Its efficacy is slightly less than that of injected gold salts, but it is better tolerated, and side effects which occur are potentially less serious.

Year introduced: 1987

PubMed search builder options

Subheadings:

Restrict to MeSH Major Topic.

Do not include MeSH terms found below this term in the MeSH hierarchy.

Tree Number(s): D02.691.675.249.150

MeSH Unique ID: D001310

Registry Number: 3H04W2810V

Entry Terms:

• Ridaura
• SK and F D 39162
• SK and F-39162
• SK and F39162
• SK and F 39162
• Ridauran
• Crisinor

Previous Indexing:

• Gold (1966-1974)
• Gold Thioglucose/analogs and derivatives (1975-1986)

Pharmacologic Action:

• Antirheumatic Agents

All MeSH Categories
Chemicals and Drugs Category
Organic Chemicals
Organometallic Compounds
Organogold Compounds
Aurothioglucose
Auranofin